Péč, M.J.; Jurica, J.; Péčová, M.; Nagy, N.; Focko, B.; Miertová, Z.; Ferencová, N.; Ságová, I.; Tonhajzerová, I.; Bolek, T.;
et al. Effect of Submaximal Doses of Semaglutide in Patients with Obesity on Metabolic Profile and Serum Levels of Adipocytokines. Pharmaceuticals 2025, 18, 1364.
https://doi.org/10.3390/ph18091364
AMA Style
Péč MJ, Jurica J, Péčová M, Nagy N, Focko B, Miertová Z, Ferencová N, Ságová I, Tonhajzerová I, Bolek T,
et al. Effect of Submaximal Doses of Semaglutide in Patients with Obesity on Metabolic Profile and Serum Levels of Adipocytokines. Pharmaceuticals. 2025; 18(9):1364.
https://doi.org/10.3390/ph18091364
Chicago/Turabian Style
Péč, Martin Jozef, Jakub Jurica, Monika Péčová, Norbert Nagy, Boris Focko, Zuzana Miertová, Nikola Ferencová, Ivana Ságová, Ingrid Tonhajzerová, Tomáš Bolek,
and et al. 2025. "Effect of Submaximal Doses of Semaglutide in Patients with Obesity on Metabolic Profile and Serum Levels of Adipocytokines" Pharmaceuticals 18, no. 9: 1364.
https://doi.org/10.3390/ph18091364
APA Style
Péč, M. J., Jurica, J., Péčová, M., Nagy, N., Focko, B., Miertová, Z., Ferencová, N., Ságová, I., Tonhajzerová, I., Bolek, T., Galajda, P., Mokáň, M., & Samoš, M.
(2025). Effect of Submaximal Doses of Semaglutide in Patients with Obesity on Metabolic Profile and Serum Levels of Adipocytokines. Pharmaceuticals, 18(9), 1364.
https://doi.org/10.3390/ph18091364
